이종코로나바이러스감염증-19 추가 백신 접종 이후 발생한 새로운 중추신경계 골수세포과산화효소관련혈관염
A Case of de novo MPO-associated Central Nervous System Vasculitis Following Heterogeneous mRNA1273 COVID-19 Booster Vaccination
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The coronavirus disease-19 (COVID-19) pandemic leaded to inevitable expeditious vaccine rollout without sufficient safety profile. Especially, severe acute respiratory syndrome coronavirus 2 infection has known to induce overreacted immune responses such as releasing of proteinase-3 and myeloperoxidase (MPO) by neutrophil. This overreacted immune response leads to the concern of the development of autoimmune diseases after COVID-19 vaccination. We report the case of de novo MPO-associated systemic vasculitis involving central nervous system following heterogeneous mRNA1273 COVID-19 booster vaccination.
Abstract
The coronavirus disease-19 (COVID-19) pandemic leaded to inevitable expeditious vaccine rollout without sufficient safety profile. Especially, severe acute respiratory syndrome coronavirus 2 infection has known to induce overreacted immune responses such as releasing of proteinase-3 and myeloperoxidase (MPO) by neutrophil. This overreacted immune response leads to the concern of the development of autoimmune diseases after COVID-19 vaccination. We report the case of de novo MPO-associated systemic vasculitis involving central nervous system following heterogeneous mRNA1273 COVID-19 booster vaccination.
참고문헌 (10)
- Doubrovinskaia S, "Neuroligocal autoimmune disease following vaccinations against severe respiratory syndrome coronavirus 2(SARS-CoV-2) : A follow-up study", Eur J Neurol, 30, pp.463~473 (2023)
- Prabhahar A, "ANAC-associated vasculitis following ChAdOx1nCoV19 vaccination : case-bsed review", Rheumatol Int, 42, pp.749~758 (2022)
- Gelzo M, "A transient increase in the serum ANCAs in patients with SARS-CoV-2 infection: A signal of sublinical vasculitis or an epiphenomenon with no clinical manifestations? A pilot study", Viruses, 13, pp.1718~ (2021)
- Nakazawa D, "Pathogenesis and therapeutic interventions for ANCA-associated vasculitis", Nat Rev Rheumatol, 15, pp.91~101 (2019)
- Shakoor MT, "ANCA-associated vasculitis is following Pfizer-BioNtech COVID-19 vaccine", Am J Kidney Dis, 78, pp.611~613 (2021)
- Anderegg MA, "De novo vasculitis after mRNA-1273(Moderna)vaccination", Kidney Int, 100, pp.474~476 (2021)
- Davidovic T, "De novo and relapsing glomerulonephritis following SARS-CoV-2 mRNA vacciation in microscopic polyangiitis", Case Rep Nephrol, 2021, pp.8400842~ (2021)
- Turner JS, "SARS-Cov-2 mRNA vaccines induce persistent human germinal centre reponses", Nature, 596, pp.109~113 (2021)
- Teijaro JR, "COVID-19 vaccines : modes of immune activation and future challenges", Nat Rev immunol, 21, pp.195~197 (2021)
- Atmar RL, "Homologous and heterologous Covid-19 booster vaccinations", N Eng J Med, 386, pp.1046~1057 (2022)